Fiche société
National Taiwan University Hospital
Traitements, essais et publications liés.
Traitements17programmes
Essais13liés
Publications3liées
SourceDBlocale
Traitements
17| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| 'Intra-luminal radiofrequency ablation (Habib EndoHPB)Only a small proportion of patients with biliary obstruction caused by hepatopancreatobiliary malignancies are suitable for surgical resection. Therefore, most patients with malignant biliary obstruction will need palliation of their obstructive jaundice to relieve the symptoms and prevent life threatening complications such as biliary sepsis. The endoscopic or percutaneous/transhepatic routes, such as endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC), and stents are accepted approaches for the relief of jaundice in malignant biliary obstruction. Improvement in the bilirubin level is also essential before palliative chemotherapy is considered in these patients. However, tumor ingrowth still remains a major cause of obstruction. In this trial, the investigators will use HabibTM EndoHPB (EMcision Ltd., UK) catheter which was used for the endobiliary radiofrequency ablation (RFA) treatment as a form of neoadjuvant therapy in hepatopancreatobiliary adenocarcinoma. | Cancer | Non applicable | Traitement symptomatique | À vérifier | |
| Empagliflozin 25 MGIn patients with ESRD, up to 20% of patients suffer from HFrEF, leading to significant CV morbidity and mortality. Several drug classes that provide survival benefits for patients with HFrEF, including SGLT2i, lack data regarding their efficacy and safety in patients under chronic hemodialysis. As the primary target of SGLT2i is expressed mostly in the kidneys, the efficacy of SGLT2i in patients with ESRD may be limited. On the other hand, patients with ESRD are at higher risks of experiencing cardiovascular events and may still benefit from treatment. Several mechanistic studies have demonstrated direct actions of SGLT2i on the myocardium, thus it is possible that the benefits of SGLT2i on heart failure are independent of their glycosuric actions and may still be present in anuric subjects. Furthermore, pharmacokinetics and pharmacodynamics studies on empagliflozin demonstrated that peak plasma levels of empagliflozin in subjects with renal failure/ESRD were similar to those in subjects with normal renal function. The use of empagliflozin in patients with ESRD seemed safe in terms of pharmacokinetics and pharmacodynamics, yet its efficacy remains to be explored. | Insuffisance cardiaque | Phase 4 | À vérifier | Taiwan | À vérifier |
| Focused Ultrasound for the Treatment of Pancreatic Cancer - an International RegistryThe purpose of the registry is to collect data on the performance of the focused ultrasound (FUS) technology and health outcomes. A wide variety of approaches exist for using FUS on pancreatic cancer patients, and the primary goal is to capture this broad spectrum of approaches and their impact on patients overall health. This information will help provide a better understanding of current care, and may possibly direct further, more specific investigations that will follow this registry. | Cancer | À vérifier | À vérifier | À vérifier | |
| Percutaneous coronary intervention of coronary chronic total occlusionCoronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization. | Maladie coronarienne | À vérifier | À vérifier | Taiwan | À vérifier |
| peripheral magnetic stimulationShoulder-hand syndrome is a common complication following stroke, constituting of excessive pain, swelling, heat, limited range of motion, and trophic change of the affected limbs. It not only has an extensive negative impact on both physical and psychological aspects of a stroke patient's well-being, but also impose burden on the health care system and the patient's family. Despite its relatively high incidence, there is neither well-established treatment protocol, nor high quality evidence for a single effective treatment. The objective of the present study is to investigate the efficacy, including pain, spasticity, and subluxation reduction, muscle strengthening, and shoulder range of motion improvement, of high-intensity peripheral magnetic stimulation generated by the super-inductive system to treat patients with post-stroke shoulder-hand syndrome. | Accident vasculaire cérébral | Non applicable | Traitement symptomatique | Taiwan | À vérifier |
| plasmapheresisDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | Non applicable | À vérifier | Taiwan | À vérifier |
| SMART-2 — Sleep, Music, And Research Trial 2.0The goal of this clinical trial is to learn if a music-based intervention works to improve sleep and health in children with epilepsy and their parents. The main question it aims to answer is: Does the music-based intervention improve sleep and health for both the children and their parents? | Épilepsie | Non applicable | À vérifier | Taiwan | À vérifier |
| The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive PatientsNifedipine and barnidipine act as calcium channel blockers, and are widely prescribed for pressure control of prehypertension and stage 1 hypertension. CYP3A4 is responsible for the metabolism of nifedipine and nifedipine, while the contribution of CYP3A5 remains ambiguous. This study is aimed to analyze the association between antihypertensive effects of nifedipine as well as barnidipine and single nucleotide polymorphisms of CYP3A4, CYP3A5 and calcium channels. | Hypertension | À vérifier | À vérifier | À vérifier | |
| The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive PatientsNifedipine and barnidipine act as calcium channel blockers, and are widely prescribed for pressure control of prehypertension and stage 1 hypertension. CYP3A4 is responsible for the metabolism of nifedipine and nifedipine, while the contribution of CYP3A5 remains ambiguous. This study is aimed to analyze the association between antihypertensive effects of nifedipine as well as barnidipine and single nucleotide polymorphisms of CYP3A4, CYP3A5 and calcium channels. | Hypertension | À vérifier | À vérifier | À vérifier | |
| plasmapheresisDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | Non applicable | À vérifier | Taiwan | À vérifier |
| plasmapheresisDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | Non applicable | À vérifier | Taiwan | À vérifier |
| Focused Ultrasound for the Treatment of Pancreatic Cancer - an International RegistryThe purpose of the registry is to collect data on the performance of the focused ultrasound (FUS) technology and health outcomes. A wide variety of approaches exist for using FUS on pancreatic cancer patients, and the primary goal is to capture this broad spectrum of approaches and their impact on patients overall health. This information will help provide a better understanding of current care, and may possibly direct further, more specific investigations that will follow this registry. | Cancer | À vérifier | À vérifier | À vérifier | |
| SMART-2 — Sleep, Music, And Research Trial 2.0The goal of this clinical trial is to learn if a music-based intervention works to improve sleep and health in children with epilepsy and their parents. The main question it aims to answer is: Does the music-based intervention improve sleep and health for both the children and their parents? | Épilepsie | Non applicable | À vérifier | Taiwan | À vérifier |
| Percutaneous coronary intervention of coronary chronic total occlusionCoronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization. | Maladie coronarienne | À vérifier | À vérifier | Taiwan | À vérifier |
| peripheral magnetic stimulationShoulder-hand syndrome is a common complication following stroke, constituting of excessive pain, swelling, heat, limited range of motion, and trophic change of the affected limbs. It not only has an extensive negative impact on both physical and psychological aspects of a stroke patient's well-being, but also impose burden on the health care system and the patient's family. Despite its relatively high incidence, there is neither well-established treatment protocol, nor high quality evidence for a single effective treatment. The objective of the present study is to investigate the efficacy, including pain, spasticity, and subluxation reduction, muscle strengthening, and shoulder range of motion improvement, of high-intensity peripheral magnetic stimulation generated by the super-inductive system to treat patients with post-stroke shoulder-hand syndrome. | Accident vasculaire cérébral | Non applicable | Traitement symptomatique | Taiwan | À vérifier |
| 'Intra-luminal radiofrequency ablation (Habib EndoHPB)Only a small proportion of patients with biliary obstruction caused by hepatopancreatobiliary malignancies are suitable for surgical resection. Therefore, most patients with malignant biliary obstruction will need palliation of their obstructive jaundice to relieve the symptoms and prevent life threatening complications such as biliary sepsis. The endoscopic or percutaneous/transhepatic routes, such as endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC), and stents are accepted approaches for the relief of jaundice in malignant biliary obstruction. Improvement in the bilirubin level is also essential before palliative chemotherapy is considered in these patients. However, tumor ingrowth still remains a major cause of obstruction. In this trial, the investigators will use HabibTM EndoHPB (EMcision Ltd., UK) catheter which was used for the endobiliary radiofrequency ablation (RFA) treatment as a form of neoadjuvant therapy in hepatopancreatobiliary adenocarcinoma. | Cancer | Non applicable | Traitement symptomatique | À vérifier | |
| Empagliflozin 25 MGIn patients with ESRD, up to 20% of patients suffer from HFrEF, leading to significant CV morbidity and mortality. Several drug classes that provide survival benefits for patients with HFrEF, including SGLT2i, lack data regarding their efficacy and safety in patients under chronic hemodialysis. As the primary target of SGLT2i is expressed mostly in the kidneys, the efficacy of SGLT2i in patients with ESRD may be limited. On the other hand, patients with ESRD are at higher risks of experiencing cardiovascular events and may still benefit from treatment. Several mechanistic studies have demonstrated direct actions of SGLT2i on the myocardium, thus it is possible that the benefits of SGLT2i on heart failure are independent of their glycosuric actions and may still be present in anuric subjects. Furthermore, pharmacokinetics and pharmacodynamics studies on empagliflozin demonstrated that peak plasma levels of empagliflozin in subjects with renal failure/ESRD were similar to those in subjects with normal renal function. The use of empagliflozin in patients with ESRD seemed safe in terms of pharmacokinetics and pharmacodynamics, yet its efficacy remains to be explored. | Insuffisance cardiaque | Phase 4 | À vérifier | Taiwan | À vérifier |
Essais cliniques
13| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Empagliflozin 25 MG | Insuffisance cardiaque | Phase 4 | NCT06249932 | EMPA-RRED — Empagliflozin in Heart Failure With Reduced Ejection Fraction and End Stage Renal Disease | RECRUITING |
| 'Intra-luminal radiofrequency ablation (Habib EndoHPB) | Cancer | Non applicable | NCT02841800 | Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis | COMPLETED |
| peripheral magnetic stimulation | Accident vasculaire cérébral | Non applicable | NCT05112094 | Peripheral Magnetic Stimulation to Treat Patient With Post-stroke Shoulder-hand Syndrome | COMPLETED |
| Percutaneous coronary intervention of coronary chronic total occlusion | Maladie coronarienne | À vérifier | NCT06917378 | TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion) | RECRUITING |
| Melatonin | Épilepsie | Phase 2/3 | NCT05439876 | Getting SMART for Pediatric Epilepsy | COMPLETED |
| Histotripsie — HistoSonics Edison System | Cancer | Non applicable | NCT07207343 | Symptomatic Abdominal Tumors Are Unsuitable for Surgical Resection, High-intensity Focused Ultrasound (HIFU) Treatment Will be Applied to the Tumors. Postoperatively, Continuous Evaluation and Analysis of the Ablation Effect Will be Performed Using CT or MRI Imaging. | ACTIVE_NOT_RECRUITING |
| SMART-2 — Sleep, Music, And Research Trial 2.0 | Épilepsie | Non applicable | NCT07696442 | SMART-2 — Sleep, Music, And Research Trial 2.0 | NOT_YET_RECRUITING |
| Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry | Cancer | À vérifier | NCT05010226 | Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry | NOT_YET_RECRUITING |
| plasmapheresis | Sclérose latérale amyotrophique | Non applicable | NCT05562960 | PALATIN — Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP | COMPLETED |
| plasmapheresis | Sclérose latérale amyotrophique | Non applicable | NCT07726563 | Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2) | RECRUITING |
| Histotripsie — HistoSonics Edison System | Cancer | Non applicable | NCT07063771 | Safety and Clinical Efficacy of Histotripsy for Liver Cancers Adjacent to Major Intrahepatic Vessels | NOT_YET_RECRUITING |
| Histotripsie — HistoSonics Edison System | Cancer | Non applicable | NCT07180706 | To Evaluate the Safety and Efficacy of Histotripsy for the Symptom Relief of Inoperable Abdominal Tumors | NOT_YET_RECRUITING |
| The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients | Hypertension | À vérifier | NCT00728858 | The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients | COMPLETED |
Publications
3| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| plasmapheresis | Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review. | Journal of neuroimmunology | ||
| plasmapheresis | Neuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform. | Journal of the neurological sciences | ||
| plasmapheresis | Risk factors for hypotension and technical complications during single-session double-filtration plasmapheresis: a 15-year retrospective study of 1,022 procedures. | Renal failure |